Enveric Biosciences Inc (NASDAQ:ENVB) has a beta value of 0.73 and has seen 16.22 million shares traded in the recent trading session. The company, currently valued at $3.39M, closed the recent trade at $0.38 per share which meant it lost -$0.03 on the day or -7.84% during that session. The ENVB stock price is -668.42% off its 52-week high price of $2.92 and -7.89% below the 52-week low of $0.41. If we look at the company’s 10-day average daily trading volume, we find that it stood at 69090.0 shares traded. The 3-month trading volume is 1.09 million shares.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Sporting -7.84% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ENVB stock price touched $0.38 or saw a rise of 15.56%. Year-to-date, Enveric Biosciences Inc shares have moved -70.79%, while the 5-day performance has seen it change -8.51%. Over the past 30 days, the shares of Enveric Biosciences Inc (NASDAQ:ENVB) have changed -24.21%. Short interest in the company has seen 0.2 million shares shorted with days to cover at 1.86.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Enveric Biosciences Inc (ENVB) estimates and forecasts
Figures show that Enveric Biosciences Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -58.32% over the past 6 months, with this year growth rate of 74.03%, compared to 17.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 71.22% over the past 5 years.
ENVB Dividends
Enveric Biosciences Inc is expected to release its next earnings report on 2024-Nov-11 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
Insiders own 2.42% of the company shares, while shares held by institutions stand at 5.67% with a share float percentage of 5.81%. Investors are also buoyed by the number of investors in a company, with Enveric Biosciences Inc having a total of 15.0 institutions that hold shares in the company. The top two institutional holders are ADVISORSHARES INVESTMENTS LLC with over 0.32 million shares worth more than $0.19 million. As of 2024-06-30, ADVISORSHARES INVESTMENTS LLC held 7.9233% of shares outstanding.
The other major institutional holder is GEODE CAPITAL MANAGEMENT, LLC, with the holding of over 44659.0 shares as of 2024-06-30. The firm’s total holdings are worth over $27688.0 and represent 1.1161% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity NASDAQ Composite Index Fund. As of Sep 30, 2024, the former fund manager holds about 4.11% shares in the company for having 367.05 shares of worth $0.14 million while later fund manager owns 163.68 shares of worth $60546.0 as of Aug 31, 2024, which makes it owner of about 1.84% of company’s outstanding stock.
